Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models

Background CD3 bispecific antibodies (CD3-bsAbs) require binding of both a tumor-associated surface antigen and CD3 for their immunotherapeutic effect. Their efficacy is, therefore, influenced by the tumor uptake and the extracellular dose. To optimize their currently limited efficacy in solid tumor...

Full description

Bibliographic Details
Main Authors: Thorbald van Hall, Jim Middelburg, Gerwin Gerhard Wemke Sandker, Evienne Wilbrink, Janneke Molkenboer-Kuenen, Erik Aarntzen, Sandra Heskamp
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/10/e007596.full